↓ Skip to main content

Mammalian Cell Cultures for Biologics Manufacturing

Overview of attention for book
Attention for Chapter 255: Mammalian Cell Cultures for Biologics Manufacturing.
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#4 of 197)
  • High Attention Score compared to outputs of the same age (95th percentile)

Mentioned by

news
4 news outlets

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
157 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Mammalian Cell Cultures for Biologics Manufacturing.
Chapter number 255
Book title
Mammalian Cell Cultures for Biologics Manufacturing
Published in
Advances in biochemical engineering biotechnology, November 2013
DOI 10.1007/10_2013_255
Pubmed ID
Book ISBNs
978-3-64-254049-3, 978-3-64-254050-9
Authors

Kantardjieff A, Zhou W, Anne Kantardjieff, Weichang Zhou

Abstract

Biopharmaceuticals represent a growing sector of the pharmaceutical industry, and are used for a wide range of indications, including oncology and rheumatology. Cultured mammalian cells have become the predominant expression system for their production, partly due to their ability to complete the posttranslational modifications required for drug safety and efficacy. Over the past decade, the productivity of mammalian cell culture production processes has growth dramatically through improvements in both volumetric and specific productivities. This article presents an overview of the biologics market, including analysis of sales and approvals; as well as a review of industrial production cell lines and cell culture operations.

Mendeley readers

The data shown below were compiled from readership statistics for 157 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Switzerland 1 <1%
India 1 <1%
Iran, Islamic Republic of 1 <1%
Belgium 1 <1%
United States 1 <1%
Unknown 152 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 42 27%
Student > Master 37 24%
Researcher 22 14%
Student > Bachelor 21 13%
Other 10 6%
Other 10 6%
Unknown 15 10%
Readers by discipline Count As %
Agricultural and Biological Sciences 54 34%
Biochemistry, Genetics and Molecular Biology 29 18%
Engineering 25 16%
Chemical Engineering 8 5%
Pharmacology, Toxicology and Pharmaceutical Science 8 5%
Other 16 10%
Unknown 17 11%

Attention Score in Context

This research output has an Altmetric Attention Score of 31. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 June 2019.
All research outputs
#648,081
of 15,314,498 outputs
Outputs from Advances in biochemical engineering biotechnology
#4
of 197 outputs
Outputs of similar age
#9,273
of 189,695 outputs
Outputs of similar age from Advances in biochemical engineering biotechnology
#2
of 2 outputs
Altmetric has tracked 15,314,498 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 197 research outputs from this source. They receive a mean Attention Score of 3.6. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 189,695 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one.